IPG Photonics Acquires Lumibird Medical for €300M to Expand Medical Laser Business
IPG Photonics (NASDAQ:IPGP) has signed a binding offer to acquire Lumibird Medical, a medical laser systems business focused on ophthalmology, for €300 million plus a potential €50 million earn-out. The deal aims to expand IPG's exposure to higher-margin medical markets, particularly ophthalmology, and increase its advanced solutions revenue mix from 16% to about 26% of total sales based on 2025 pro forma results. IPG expects the acquisition to be accretive to gross margin, EBITDA, and adjusted EPS in the first year. The company plans to fund the purchase with cash on hand and maintain a strong balance sheet. Lumibird Medical has over 80,000 systems installed globally, more than 450 employees, and facilities in France, Australia, and Slovenia. The acquisition is expected to close by the end of Q4 2026.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection